Literature DB >> 24992711

The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth.

Heiani Touaitahuata1, Gaelle Cres1, Sylvain de Rossi2, Virginie Vives1, Anne Blangy3.   

Abstract

During long bone development and post-natal growth, the cartilaginous model of the skeleton is progressively replaced by bone, a process known as endochondral ossification. In the primary spongiosa, osteoclasts degrade the mineralized cartilage produced by hypertrophic chondrocytes to generate cartilage trabeculae that osteoblasts embed in bone matrix. This leads to the formation of the trabecular bone network of the secondary spongiosa that will undergo continuous remodeling. Osteoclasts are specialized in mineralized tissue degradation, with the combined ability to solubilize hydroxyapatite and to degrade extracellular matrix proteins. We reported previously that osteoclasts lacking Dock5 could not degrade bone due to abnormal podosome organization and absence of sealing zone formation. Consequently, adult Dock5(-/-) mice have increased trabecular bone mass. We used Dock5(-/-) mice to further investigate the different functions of osteoclast during endochondral bone formation. We show that long bones are overall morphologically normal in developing and growing Dock5(-/-) mice. We demonstrate that Dock5(-/-) mice also have normal hypertrophic cartilage and cartilage trabecular network. Conversely, trabecular bone volume increased progressively in the secondary spongiosa of Dock5(-/-) growing mice as compared to Dock5(+/+) animals, even though their osteoclast numbers were the same. In vitro, we show that Dock5(-/-) osteoclasts do present acidic compartments at the ventral plasma membrane and produce normal amounts of active MMP9, TRAP and CtsK for matrix protein degradation but they are unable to solubilize minerals. These observations reveal that contrarily to bone resorption, the ability of osteoclasts to dissolve minerals is dispensable for the degradation of mineralized hypertrophic cartilage during endochondral bone formation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Developmental modeling; Dock5; Endochondral ossification; Growth plate; Osteoclasts

Mesh:

Substances:

Year:  2014        PMID: 24992711     DOI: 10.1016/j.ydbio.2014.06.020

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  15 in total

1.  MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.

Authors:  Bo Yuan; Zhiming Wu
Journal:  Oncol Lett       Date:  2017-12-29       Impact factor: 2.967

2.  Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.

Authors:  Harini Raghu; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Eric S Mullins; Jonathan G Schoenecker; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

3.  Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice.

Authors:  Su-Guo Yu; Cheng-Jie Zhang; Xiu-E Xu; Ji-Hua Sun; Li Zhang; Peng-Fei Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

4.  Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts.

Authors:  Brandon M Wagner; Jerid W Robinson; Timothy C R Prickett; Eric A Espiner; Sundeep Khosla; Dana Gaddy; Larry J Suva; Lincoln R Potter
Journal:  Calcif Tissue Int       Date:  2022-08-10       Impact factor: 4.000

5.  Osteoclast depletion with clodronate liposomes delays fracture healing in mice.

Authors:  Hsuan-Ni Lin; J Patrick O'Connor
Journal:  J Orthop Res       Date:  2016-10-06       Impact factor: 3.494

6.  Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats.

Authors:  Xianrong Zhang; Yangfan Shang-Guan; Jing Ma; Hang Hu; Linlong Wang; Jacques Magdalou; Liaobin Chen; Hui Wang
Journal:  Br J Pharmacol       Date:  2016-06-02       Impact factor: 8.739

7.  Overexpression of Indian hedgehog partially rescues short stature homeobox 2-overexpression-associated congenital dysplasia of the temporomandibular joint in mice.

Authors:  Xihai Li; Wenna Liang; Hongzhi Ye; Xiaping Weng; Fayuan Liu; Pingdong Lin; Xianxiang Liu
Journal:  Mol Med Rep       Date:  2015-06-18       Impact factor: 2.952

8.  Mutations in DYNC2LI1 disrupt cilia function and cause short rib polydactyly syndrome.

Authors:  S Paige Taylor; Tiago J Dantas; Ivan Duran; Sulin Wu; Ralph S Lachman; Stanley F Nelson; Daniel H Cohn; Richard B Vallee; Deborah Krakow
Journal:  Nat Commun       Date:  2015-06-16       Impact factor: 14.919

9.  Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis.

Authors:  Yuanxin Liu; Guilai Zuo; Xin Meng; Xingxiao Gao; Lihai Zhang; Peifu Tang
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

10.  NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue.

Authors:  Angélica Rivera-Villaseñor; Frida Higinio-Rodríguez; Laura Nava-Gómez; Bárbara Vázquez-Prieto; Isnarhazni Calero-Vargas; Rafael Olivares-Moreno; Mónica López-Hidalgo
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.